Atlas Trials

The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction

Clinical trial NCT07103655 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07103655
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Hypertrophic Cardiomyopathy (HCM)
Start date
2026-01-01
Primary completion
2026-07-01
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.